Welcome to LookChem.com Sign In|Join Free

CAS

  • or

37904-72-6

Post Buying Request

37904-72-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37904-72-6 Usage

Description

2-BROMO-1-(4-DIMETHYLAMINO-PHENYL)-ETHANONE is an organic compound with the chemical structure featuring a bromo group and a dimethylaminophenyl group attached to an ethanone backbone. 2-BROMO-1-(4-DIMETHYLAMINO-PHENYL)-ETHANONE has potential applications in various fields due to its unique chemical properties.

Uses

Used in Medical Research:
2-BROMO-1-(4-DIMETHYLAMINO-PHENYL)-ETHANONE is used as a potential biomarker for respiratory illnesses. Its presence in biological samples can indicate the presence or severity of certain respiratory conditions, aiding in diagnosis and treatment planning.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-BROMO-1-(4-DIMETHYLAMINO-PHENYL)-ETHANONE can be utilized as a key intermediate in the synthesis of various drugs targeting respiratory diseases. Its unique chemical structure allows for the development of novel therapeutic agents with improved efficacy and safety profiles.
Used in Chemical Research:
2-BROMO-1-(4-DIMETHYLAMINO-PHENYL)-ETHANONE can also be employed in chemical research as a starting material for the synthesis of other organic compounds with potential applications in various industries, such as materials science, agrochemicals, and environmental science.

Check Digit Verification of cas no

The CAS Registry Mumber 37904-72-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,9,0 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 37904-72:
(7*3)+(6*7)+(5*9)+(4*0)+(3*4)+(2*7)+(1*2)=136
136 % 10 = 6
So 37904-72-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H12BrNO/c1-12(2)9-5-3-8(4-6-9)10(13)7-11/h3-6H,7H2,1-2H3

37904-72-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-1-(4-(dimethylamino)phenyl)ethanone

1.2 Other means of identification

Product number -
Other names 2-bromo-1-[4-(dimethylamino)phenyl]ethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:37904-72-6 SDS

37904-72-6Relevant articles and documents

Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL

Yang, Lixin,Liu, Yongqing,Fan, Minghua,Zhu, Guiwang,Jin, Hongwei,Liang, Jing,Liu, Zhenming,Huang, Zhuo,Zhang, Liangren

, (2019/09/07)

Chemical probes of epigenetic ‘readers’ of histone post-translational modifications (PTMs) have become powerful tools for mechanistic and functional studies of their target proteins in physiology and pathology. However, only limited ‘reader’ probes have been developed, which restricted our understanding towards these macromolecules and their roles in cells or animals. Here, we reported a structure-guided approach to develop and characterize benzo [d]oxazol-2(3H)-one analogs as the first potent and selective small-molecule inhibitors of chromodomain Y-like (CDYL), a histone methyllysine reader protein. The binding conformation between the chromodomain of CDYL and the modified peptidomimetics was studied via molecular docking and dynamic simulations, facilitating subsequent virtual screening of tens of hits from Specs chemical library validated by SPR technique (KD values: from 271.1 μM to 5.4 μM). Further design and synthesis of 43 compounds helped to interpret the structure-activity relationship (SAR) that lead to the discovery of novel small-molecule inhibitors of CDYL. Compound D03 (KD: 0.5 μM) was discovered and showed excellent selectivity among other chromodomain proteins, including CDYL2 (>140 folds), CDY1 (no observed binding) and CBX7 (>32 folds). Moreover, we demonstrated that D03 engaged with endogenous CDYL in a dose-dependent manner, and perturbed the recruitment of CDYL onto chromatin, resulting in transcriptional derepression of its target genes. Finally, the results showed that D03 promoted the development and branching of neurodendrites by inhibiting CDYL in hippocampal and cortical cultured neurons. This study not only discovers the first selective small-molecule inhibitors of CDYL, but provids a new chemical tool to intervene the dynamic nature of bio-macromolecules involved in epigenetic mechanism.

Radiosynthesis of SPECT tracers: Via a copper mediated 123I iodination of (hetero)aryl boron reagents

Wilson, Thomas C.,McSweeney, Greg,Preshlock, Sean,Verhoog, Stefan,Tredwell, Matthew,Cailly, Thomas,Gouverneur, Véronique

supporting information, p. 13277 - 13280 (2016/11/17)

A general method for the copper mediated nucleophilic 123I-iodination of (hetero)aryl boronic esters and acids has been developed. The broad substrate scope of this radiosynthetic approach allows access to [123I]DPA-713, [123I]IMPY, [123I]MIBG and [123I]IPEB that are four commonly used SPECT radiotracers. Our results infer that aryl boronic reagents can now be employed as common precursors for both fluorine-18 and iodine-123 radiolabelling.

INHIBITORS OF HISTONE DEACETYLASE

-

Paragraph 0272, (2016/04/26)

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 37904-72-6